Tag: MyoRegulator device

PathMaker initiates US multicentre trial evaluating non-invasive post-stroke spasticity treatment

PathMaker Neurosystems has announced initiation of its US multicentre clinical trial to evaluate MyoRegulator for the non-invasive treatment of post-stroke upper-limb spasticity. The trial is...

Companies partner for a non-invasive neuromodulation device to treat spasticity

WeHealth by Servier, the e-health department of Servier Group, and PathMaker Neurosystems, have announced the closing of a partnership agreement to develop and commercialise...